Belgium· BE-AMP-SAM541440-00
Ajovy 225 mg
A fremanezumab product containing fremanezumab, registered in Belgium by Teva. The same ATC class is registered in 15 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Fremanezumab is registered in 15 of 19 countries.
Countries holding a registration under ATC N02CD03 (fremanezumab), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 10 of them publish a price we can compare per daily dose
Fremanezumab · ATC N02CD03
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Fremanezumab
- Manufacturer
- Teva
- Country
- Belgium (BE)
- ATC code
- N02CD03
- ATC class
- Fremanezumab
- Defined daily dose
- 7.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 3
2 priced- be_apb3960796EUR 1469.43
- be_apb3960788EUR 497.13
- be_apb7730898
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fremanezumab in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAJOVYTeva GmbH, Ulm
- SwedenAJOVY 225 mg Injektionsvätska, lösning i förfylld injektionspennaTEVA GmbH
- SpainAJOVY 225 MG SOLUCION INYECTABLE EN JERINGA PRECARGADATeva Gmbh
- IcelandAJOVYTEVA GmbH
- NorwayAjovyTeva GmbH
- SwitzerlandAJOVY 225 mg, Injektionslösung im FertigpenTeva Pharma AG
- PolandAjovyTEVA GmbH
- United StatesAJOVYTeva Pharmaceuticals USA, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Ajovy
- Iceland · Ajovy
- Liechtenstein · Ajovy
- Norway · Ajovy
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/901ffbe9-fb69-4cba-8ba4-19c0c81b3f06 GET /v1/drugs/901ffbe9-fb69-4cba-8ba4-19c0c81b3f06?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in pre-filled syringe",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Ajovy 225 mg",
"name_fr": "Ajovy 225 mg",
"name_nl": "Ajovy 225 mg",
"amp_code": "SAM541440-00",
"strengths": [
"150.0000"
],
"pack_count": 3,
"substances": [
"Fremanezumab",
"Disodium Ethylenediaminetetraacetic Acid (EDTA) Dihydrate",
"Sucrose",
"Polysorbate 80"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Fremanezumab",
"authorisation_numbers": [
"EU/1/19/1358/001",
"EU/1/19/1358/002"
]
}See everything about fremanezumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.